May 7, 2026 04:15PM
Apr 20, 2026 10:21AM
Apr 20, 2026 07:43AM
Apr 20, 2026 07:30AM
Mar 28, 2026 12:36PM
Mar 28, 2026 12:36PM
Mar 20, 2026 10:00AM Nektar gets two presentations at dermatology meeting for drug trials
Mar 20, 2026 10:00AM
Mar 10, 2026 09:08AM
Feb 19, 2026 05:31PM
Feb 17, 2026 07:00AM
Feb 16, 2026 05:31PM
Feb 10, 2026 07:01AM
Feb 10, 2026 07:00AM New REZOLVE-AD Maintenance Data in Atopic Dermatitis Demonstrate Rezpegaldesleukin Resulted in Durable and New Responses Across Key Disease Measurements with Both Monthly and Quarterly Dosing
Dec 16, 2025 07:30AM
Dec 16, 2025 07:30AM
Nov 8, 2025 05:45PM
Nov 6, 2025 04:15PM
Oct 22, 2025 08:00AM
Sep 18, 2025 08:46AM
Sep 18, 2025 08:45AM Nektar Presents New Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin in Late-Breaker Oral Presentation at EADV 2025
Sep 9, 2025 07:00AM
Aug 7, 2025 04:15PM
Jul 29, 2025 09:01AM
Jul 29, 2025 09:00AM
Jun 24, 2025 07:31AM
Jun 24, 2025 07:30AM
May 8, 2025 04:15PM Nektar Therapeutics Reports First Quarter 2025 Financial Results
Mar 12, 2025 04:15PM
Feb 26, 2025 07:01AM
Feb 26, 2025 07:00AM
Feb 24, 2025 07:00AM
Feb 24, 2025 07:00AM
Feb 24, 2025 07:00AM
Feb 10, 2025 07:01AM Nektar Therapeutics (NKTR) Receives Fast Track Designation for Rezpegaldesleukin
Feb 10, 2025 07:00AM
Dec 7, 2024 12:00PM
Nov 4, 2024 08:30AM
Nov 4, 2024 08:30AM
Mar 19, 2024 04:15PM
Jan 22, 2024 08:23AM
Dec 12, 2022 10:05AM Nektar Announces Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting
Apr 29, 2022 06:59AM
Apr 14, 2022 04:33PM
Apr 14, 2022 04:30PM
Mar 15, 2022 06:37AM
Mar 14, 2022 07:00AM
Mar 14, 2022 06:59AM
Sep 21, 2021 09:00AM Nektar Announces New Clinical Collaboration with Merck KGaA Darmstadt, Germany and Pfizer Inc. to Combine NKTR-255, a Novel Interleukin-15 Agonist, with Avelumab in the JAVELIN Bladder Medley Study
Nov 11, 2020 02:00PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All